Chordate Medical Holding AB (CMH) - Cash Flow Conversion Efficiency

Latest as of June 2025: -0.514x

Based on the latest financial reports, Chordate Medical Holding AB (CMH) has a cash flow conversion efficiency ratio of -0.514x as of June 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-7.14 Million ≈ $-768.45K USD) by net assets (Skr13.90 Million ≈ $1.50 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see Chordate Medical Holding AB (CMH) market capitalisation for the company's overall valuation and market capitalisation.

Chordate Medical Holding AB - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how Chordate Medical Holding AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Chordate Medical Holding AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Chordate Medical Holding AB ranked by their cash flow conversion efficiency. See cash flow to debt ratio of Chordate Medical Holding AB to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
FAT Brands Inc NASDAQ:FATBW	0.050x
Carisma Therapeutics Inc. NASDAQ:CARM	-2.201x
t42 IoT Tracking Solutions PLC LSE:TRAC	-0.185x
STRATA Skin Sciences Inc NASDAQ:SSKN	-0.082x
Physiomics Plc LSE:PYC	-0.514x
Anemoi International Ltd LSE:AMOI	-0.089x
Litigation Capital Management Limited LSE:LIT	-0.088x
WICKET GAMING AB F:7Q4	0.015x

Annual Cash Flow Conversion Efficiency for Chordate Medical Holding AB (2015–2024)

The table below shows the annual cash flow conversion efficiency of Chordate Medical Holding AB from 2015 to 2024. View today's stock price for Chordate Medical Holding AB for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	Skr9.20 Million ≈ $989.55K	Skr-24.41 Million ≈ $-2.63 Million	-2.654x	-46.89%
2023-12-31	Skr15.09 Million ≈ $1.62 Million	Skr-27.26 Million ≈ $-2.93 Million	-1.807x	+19.89%
2022-12-31	Skr11.07 Million ≈ $1.19 Million	Skr-24.98 Million ≈ $-2.69 Million	-2.256x	-332.08%
2021-12-31	Skr38.95 Million ≈ $4.19 Million	Skr-20.34 Million ≈ $-2.19 Million	-0.522x	+23.19%
2020-12-31	Skr25.64 Million ≈ $2.76 Million	Skr-17.43 Million ≈ $-1.88 Million	-0.680x	+55.95%
2019-12-31	Skr10.98 Million ≈ $1.18 Million	Skr-16.95 Million ≈ $-1.82 Million	-1.543x	+8.48%
2018-12-31	Skr11.26 Million ≈ $1.21 Million	Skr-18.99 Million ≈ $-2.04 Million	-1.686x	-61.95%
2017-12-31	Skr18.24 Million ≈ $1.96 Million	Skr-18.99 Million ≈ $-2.04 Million	-1.041x	-219.15%
2016-12-31	Skr29.55 Million ≈ $3.18 Million	Skr-9.64 Million ≈ $-1.04 Million	-0.326x	+6.19%
2015-12-31	Skr35.72 Million ≈ $3.84 Million	Skr-12.42 Million ≈ $-1.34 Million	-0.348x	--

About Chordate Medical Holding AB

ST:CMH Sweden Medical Devices

Market Cap

$29.05K

Skr269.96K SEK

Market Cap Rank

#31709 Global

#749 in Sweden

Share Price

Skr0.10

Change (1 day)

-37.50%

52-Week Range

Skr0.10 - Skr5.88

All Time High

Skr439.49